Current population · 2,231
Benzylpenicillin versus flucloxacillin or cloxacillin for the treatment of pe...
Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
← ExplorerSource ↗Publication identity
Publication IDCPD-2170
Year2026
PMID42309115
DOI10.1016/S0140-6736(26)00761-0. Online ahead of print
JournalLancet
AuthorsStaphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
First authorStaphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
Senior authorStaphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
Scientific classification
Research themeClinical infectious diseases
Pathogen groupStaphylococcus aureus / MRSA
Technology / methodClinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew O'Sullivan
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/42309115/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →